Antidepressant-associated mania: a study of anxiety disorders patients. 1998

D Levy, and R Kimhi, and Y Barak, and A Aviv, and A Elizur
The Y. Abarbanel Mental Health Center, Bat-Yam, (affiliated with the Sackler School of Medicine, Tel-Aviv University), Israel.

Antidepressants are related to the emergence of manic and hypomanic episodes in mood disorder patients. This study examined whether antidepressant-associated manic states are also present in anxiety disorder patients, so that this phenomenon may be defined as a side-effect. A total of 167 consecutive patients at a specialized outpatient clinic, suffering from anxiety disorders and treated by antidepressants, were assessed in a blind, retrospective chart review. Five patients (2.99%) were identified as having suffered an episode of antidepressant-associated mania within 3 months of initiation of treatment. All were females and all had an axis II diagnosis of a cluster B personality disorder. Antidepressant-associated mania appears to be related to risk factors such as personality disorder, even in non-mood disorder patients, tentatively suggesting that it is not simply an adverse event but rather a reflection of an underlying psychopathology.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000928 Antidepressive Agents Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. Antidepressant,Antidepressant Drug,Antidepressant Medication,Antidepressants,Antidepressive Agent,Thymoanaleptic,Thymoanaleptics,Thymoleptic,Thymoleptics,Antidepressant Drugs,Agent, Antidepressive,Drug, Antidepressant,Medication, Antidepressant
D001008 Anxiety Disorders Persistent and disabling ANXIETY. Anxiety Neuroses,Anxiety States, Neurotic,Neuroses, Anxiety,Anxiety Disorder,Anxiety State, Neurotic,Disorder, Anxiety,Disorders, Anxiety,Neurotic Anxiety State,Neurotic Anxiety States,State, Neurotic Anxiety,States, Neurotic Anxiety
D001714 Bipolar Disorder A major affective disorder marked by severe mood swings (manic or major depressive episodes) and a tendency to remission and recurrence. Affective Psychosis, Bipolar,Bipolar Disorder Type 1,Bipolar Disorder Type 2,Bipolar Mood Disorder,Depression, Bipolar,Manic Depression,Manic Disorder,Manic-Depressive Psychosis,Psychosis, Manic-Depressive,Type 1 Bipolar Disorder,Type 2 Bipolar Disorder,Psychoses, Manic-Depressive,Bipolar Affective Psychosis,Bipolar Depression,Bipolar Disorders,Bipolar Mood Disorders,Depression, Manic,Depressions, Manic,Disorder, Bipolar,Disorder, Bipolar Mood,Disorder, Manic,Manic Depressive Psychosis,Manic Disorders,Mood Disorder, Bipolar,Psychoses, Bipolar Affective,Psychoses, Manic Depressive,Psychosis, Bipolar Affective,Psychosis, Manic Depressive
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective

Related Publications

D Levy, and R Kimhi, and Y Barak, and A Aviv, and A Elizur
November 1992, Pharmacopsychiatry,
D Levy, and R Kimhi, and Y Barak, and A Aviv, and A Elizur
November 1994, The American journal of psychiatry,
D Levy, and R Kimhi, and Y Barak, and A Aviv, and A Elizur
November 2004, European psychiatry : the journal of the Association of European Psychiatrists,
D Levy, and R Kimhi, and Y Barak, and A Aviv, and A Elizur
May 2003, International journal of geriatric psychiatry,
D Levy, and R Kimhi, and Y Barak, and A Aviv, and A Elizur
January 1987, Acta psychiatrica Scandinavica. Supplementum,
D Levy, and R Kimhi, and Y Barak, and A Aviv, and A Elizur
January 2010, Current topics in behavioral neurosciences,
D Levy, and R Kimhi, and Y Barak, and A Aviv, and A Elizur
December 2023, Progress in neuro-psychopharmacology & biological psychiatry,
D Levy, and R Kimhi, and Y Barak, and A Aviv, and A Elizur
November 1990, The American journal of psychiatry,
D Levy, and R Kimhi, and Y Barak, and A Aviv, and A Elizur
December 1995, Canadian journal of psychiatry. Revue canadienne de psychiatrie,
D Levy, and R Kimhi, and Y Barak, and A Aviv, and A Elizur
July 1998, The Journal of clinical psychiatry,
Copied contents to your clipboard!